ORIGINAL RESEARCH article
Front. Microbiol.
Sec. Antimicrobials, Resistance and Chemotherapy
This article is part of the Research TopicDefending the Last Line: Combatting Carbapenem-Resistant PathogensView all 9 articles
Emergence of KPC-2 and NDM-13-coproducing carbapenem-resistant hypervirulent Klebsiella pneumoniae with high-risk sequence type ST11
Provisionally accepted
- 1General Hospital of Ningxia Medical University, Yinchuan, China
- 2Ningxia Medical University, Yinchuan, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background Carbapenem-resistant hypervirulent Klebsiella pneumoniae (CR-hvKp) co-producing KPC and NDM poses serious threats to public health. This study aimed to elucidate the molecular mechanisms underlying the resistance and virulence of a clinical CR-hvKP isolate coproducing KPC-2 and NDM-13 in China. Methods The K. pneumoniae strain A51998714 was isolated from a 58-year-old male patient in China in June 2024. MALDI-TOF/MS was used to species identity. Antimicrobial susceptibility testing was determined using the VITEK-2 system. Whole-genome sequencing (WGS), plasmid conjugation assays, and plasmid stability testing were conducted to characterize resistance and virulence determinants. Virulence potential was assessed using serum-killing assays. Results The CR-hvKp strain A51198714 exhibited resistance to nearly all tested antibiotics, including ceftazidime-avibactam and aztreonam. PCR and Sanger sequencing confirmed the co-occurrence of blaKPC-2 and blaNDM-13. WGS analysis revealed that strain A51198714, belonging to ST11-K64, possessed a single chromosome and five plasmids. Virulence-associated genes, localized on the IncHI1B plasmid pA51998714-VIR and the chromosome, were linked to enhanced colonization and infectivity. The serum-killing assay showed strain A51998714 was resistant to serum killing. The blaKPC-2, blaCTX-M-65, and blaTEM-1 genes were located on an IncFII plasmid pA51998714-KPC. The blaNDM-13 gene was located on plasmid pA51998714-NDM, which was classified as IncI1-I type. Conjugation assay and plasmid stability testing showed that plasmid pA51998714-NDM can be successfully transferred and maintained stably in the host. Conclusion This study reports a clinical ST11-K64 CR-hvKP strain co-producing KPC-2 and NDM-13, which carried multiple resistance genes on two resistant plasmids, along with virulence factors enhancing its pathogenicity. These findings underscore the imperative for enhanced surveillance to mitigate the dissemination of such high-risk, multidrug-resistant, and hypervirulent strains.
Keywords: Klebsiella pneumoniae, Hypervirulence, Co-producing, KPC-2, NDM-13
Received: 12 Aug 2025; Accepted: 25 Nov 2025.
Copyright: © 2025 Tao, Jin, Wang, Yang, Fu, Hu, Li and Lai. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Jia Tao
Gang Li
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.